Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma

Journal of Clinical Oncology

Volumn 34, Issue 4, 2016, Pages 307-313

  Liu, Shilei ^a,d   Wang, Rui ^a,b   Zhang, Yang ^a,b   Li, Yuan ^a,b   Cheng, Chao ^a,b   Pan, Yunjian ^a,b   Xiang, Jiaqing ^a,b   Zhang, Yawei ^a,b   Chen, Haiquan ^a,c   Sun, Yihua ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA IN SITU; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; FEMALE; FROZEN SECTION; HUMAN; INTRAOPERATIVE PERIOD; LOW RISK POPULATION; LUNG ADENOCARCINOMA; LUNG ADENOCARCINOMA IN SITU; LUNG ADENOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMALLY INVASIVE ADENOCARCINOMA; PATHOLOGY; PERIPHERAL SMALL SIZED LUNG ADENOCARCINOMA; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; ADENOCARCINOMA; KAPLAN MEIER METHOD; LUNG NEOPLASMS; PATIENT MONITORING; PROCEDURES; RETROSPECTIVE STUDY;

ADENOCARCINOMA; FEMALE; FROZEN SECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84955596349     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.4907     Document Type: Article

References (31)

1. The National Lung Screening Trial Research Team: Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368: 1980-1991, 2013
2. Ginsberg RJ, Rubinstein LV; Lung Cancer Study Group: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:615-622, 1995; discussion 622-623
3. Wisnivesky JP, Henschke CI, Swanson S, et al: Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 251:550-554, 2010
4. Dembitzer FR, Flores RM, Parides MK, et al: Impact of histologic subtyping on outcome in lobar vs sublobar resections for lung cancer: a pilot study. Chest 146:175-181, 2014
5. Tsutani Y, Miyata Y, Nakayama H, et al: Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest 145:66-71, 2014
6. Altorki NK, Yip R, Hanaoka T, et al: I-ELCAP Investigators: Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 147:754-762, 2014; discussion 762-764
7. Blasberg JD, Pass HI, Donington JS: Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol 5:1583-1593, 2010
8. Wolf AS, Richards WG, Jaklitsch MT, et al: Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg 92:1819-1823, 2011; discussion 1824-1825
9. Tsutani Y, Miyata Y, Nakayama H, et al: Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging. Ann Thorac Surg 97:1701-1707, 2014
10. Okada M, Nishio W, Sakamoto T, et al: Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 129:87-93, 2005
11. Zhang Y, Sun Y, Shen L, et al: Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable. Ann Surg Oncol 20:1949-1954, 2013
12. Zhou Q, Suzuki K, Anami Y, et al: Clinicopathologic features in resected subcentimeter lung cancer-status of lymph node metastases. Interact Cardiovasc Thorac Surg 10:53-57, 2010
13. Miller DL, Rowland CM, Deschamps C, et al: Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73:1545-1550, 2002; discussion 1550-1551
14. Travis WD, Brambilla E, Noguchi M, et al: International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244-285, 2011
15. Yoshizawa A, Motoi N, Riely GJ, et al: Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24: 653-664, 2011
16. Woo T, Okudela K, Mitsui H, et al: Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases. Pathol Int 62:785-791, 2012
17. Takahashi M, Shigematsu Y, Ohta M, et al: Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters. J Thorac Cardiovasc Surg 147:54-59, 2014
18. Lim HJ, Ahn S, Lee KS, et al: Persistent pure ground-glass opacity lung nodules ≥10 mm in diameter at CT scan: Histopathologic comparisons and prognostic implications. Chest 144:1291-1299, 2013
19. Nakamura H, Saji H, Shinmyo T, et al: Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer 87:28-33, 2015
20. Son JY, Lee HY, Lee KS, et al: Quantitative CT analysis of pulmonary ground-glass opacity nodules for the distinction of invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma. PLoS One 9:e104066, 2014
21. Van Schil PE, Asamura H, Rusch VW, et al: Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 39: 478-486, 2012
22. El-Sherif A, Fernando HC, Santos R, et al: Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 14: 2400-2405, 2007
23. Kent M, Landreneau R, Mandrekar S, et al: Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg 96:1747-1754, 2013; discussion 1754-1755
24. Chang B, Hwang JH, Choi YH, et al: Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 143:172-178, 2013
25. Nakao M, Yoshida J, Goto K, et al: Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol 7:1563-1566, 2012
26. Walts AE, Marchevsky AM: Root cause analysis of problems in the frozen section diagnosis of in situ, minimally invasive, and invasive adenocarcinoma of the lung. Arch Pathol Lab Med 136: 1515-1521, 2012
27. Yeh YC, Nitadori JI, Kadota K, et al: Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: Accuracy and interobserver agreement. Histopathology, 66: 922-938, 2014
28. Kadota K, Villena-Vargas J, Yoshizawa A, et al: Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol 38:448-460, 2014
29. Warth A, Muley T, Meister M, et al: The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438-1446, 2012
30. Hung JJ, Yeh YC, Jeng WJ, et al: Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol 32:2357-2364, 2014
31. Tsao MS, Marguet S, Le Teuff G, et al: Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. J Clin Oncol 33:3439-3446, 2015